Sesen Bio Stock Price, News & Analysis
Company Description
Sesen Bio (Nasdaq: sesn) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $128.0M.
sesn stock has gained 5.3% over the past year.
This page provides a comprehensive overview of sesn stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sesen Bio (sesn) stock. Over the past 12 months, the stock has gained 5.3%. At a market capitalization of $128.0M, sesn is classified as a micro-cap stock with approximately 203.5M shares outstanding.
Latest News
Sesen Bio has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, acquisition, conferences, dividends. View all sesn news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
sesn Company Profile & Sector Positioning
Sesen Bio (sesn) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing sesn often look at related companies in the same sector, including Oncolytics Biotech Inc (ONCY), Compugen (CGEN), TuHURA Biosciences (HURA), Io Biotech, Inc. (IOBT), and Protara Therapeutics Inc (TARA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate sesn's relative position within its industry.